| Serial Number | 99112527 |
| Word Mark | ONCOMATCH |
| Filing Date | Monday, March 31, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, January 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 17, 2026 |
| Pseudo Mark | ONCO MATCH |
| Goods and Services | cell line-derived reference standards used in clinical samples in the nature of biological preparations for use in cell cultures for medical purposes; Reference standard substances being reagents used for clinical tests for medical purposes; Reference standards being reagents used for next generation DNA sequencing and/or Polymerase chain reaction (PCR) testing for medical purposes; Reference standards being diagnostic preparations for medical purposes specifically for detecting chromosomal abnormalities; Reference standards being diagnostic preparations for medical purposes specifically for analyzing biological samples for medical purposes |
| Goods and Services | Custom manufacture of cell line-delivered products being biological preparations for medical and commercial applications; Custom manufacture of reference standards being biological preparations for use in industry and science |
| Goods and Services | Biological preparations for use in industry and science specifically for use in research laboratories, biopharmaceutical and research purposes specifically as reference standards; Biological preparations for use in industry and science specifically cancer research; Biological preparations for use in industry and science specifically for use in quality control applications; Biological preparations for use in industry and science specifically cultured ex vivo cell lines for use as reference standards for research purpose; Samples being biological preparations for use in industry and science specifically for biochemical or biological laboratory analysis for research purposes; Cell line-derived products namely, reagents for scientific and research purposes specifically for clinical investigations and for use in product testing; Reference standards being reagents used for research purposes, namely, next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing; |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 31, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 31, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 31, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Revvity Discovery Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB25 9TL GB |
| Event Date | Event Description |
| Monday, March 31, 2025 | NEW APPLICATION ENTERED |
| Monday, March 31, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 7, 2025 | ASSIGNED TO EXAMINER |
| Monday, October 13, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, October 13, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, October 13, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 11, 2025 | FINAL REFUSAL WRITTEN |
| Tuesday, November 11, 2025 | FINAL REFUSAL E-MAILED |
| Tuesday, November 11, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, January 23, 2026 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, January 23, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 23, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 23, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 11, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |